Arai Hirotaka, Abe Takehiko, Takagi Hitoshi, Mori Masatomo
Department of Gastroenterology, Maebashi Red Cross Hospital, Japan.
World J Gastroenterol. 2006 Jun 28;12(24):3866-73. doi: 10.3748/wjg.v12.i24.3866.
To evaluate the effect of three interventional treatments involving transvenous obliteration for the treatment of gastric varices, and to compare the efficacy and adverse effects of these methods.
From 1995 to 2004, 93 patients with gastric fundal varices underwent interventional radiologic embolotherapy at our hospital. Of the 93 patients, 75 were treated with the balloon-occluded retrograde transvenous obliteration (BRTO) procedure; 8 were with the percutaneous transhepatic obliteration (PTO) procedure; and 10 were with the combined BRTO and PTO therapy. A follow-up evaluation examined the rates of survival, recurrence and rebleeding of the gastric varices, worsening of esophageal varices and complications in each group.
The BRTO, PTO, and combined therapy were technically successful in 81% (75/93), 44% (8/18), and 100% (10/10) patients, respectively. Recurrence of gastric varices was found in 3 patients in the BRTO group and in 3 patients in the PTO group. Rebleeding was observed in 1 patient in the BRTO group and in 1 patient in the PTO group. The 1- and 3-year survival rates were 98% and 87% in the patients without hepatocellular carcinoma (HCC) in the BRTO group, 100% and 100% in the PTO group, and 90% and 75% in the combined therapy group, respectively.
Combined BRTO and PTO therapy may rescue cases with uncontrollable gastric fundal varices that remained even after treatment with BRTO and/or PTO, though there were limitations of our study, including retrospective nature and discrepancy in sample size between the BRTO, PTO and combined therapy groups.
评估三种经静脉闭塞介入治疗方法对胃静脉曲张的治疗效果,并比较这些方法的疗效和不良反应。
1995年至2004年,我院对93例胃底静脉曲张患者进行了介入放射栓塞治疗。93例患者中,75例行球囊闭塞逆行经静脉闭塞术(BRTO);8例行经皮经肝闭塞术(PTO);10例行BRTO与PTO联合治疗。随访评估每组患者的生存率、胃静脉曲张复发率和再出血率、食管静脉曲张恶化情况及并发症。
BRTO、PTO及联合治疗的技术成功率分别为81%(75/93)、44%(8/18)和100%(10/10)。BRTO组和PTO组各有3例患者出现胃静脉曲张复发。BRTO组和PTO组各有1例患者出现再出血。BRTO组无肝细胞癌(HCC)患者的1年和3年生存率分别为98%和87%,PTO组为100%和100%,联合治疗组为90%和75%。
BRTO与PTO联合治疗可能挽救经BRTO和/或PTO治疗后仍存在的无法控制的胃底静脉曲张病例,尽管本研究存在局限性,包括回顾性研究性质以及BRTO、PTO和联合治疗组样本量的差异。